(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 39% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 37.64%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.1%.
Seer's revenue in 2024 is $16,661,000.On average, 2 Wall Street analysts forecast SEER's revenue for 2024 to be $1,234,252,945, with the lowest SEER revenue forecast at $1,231,985,884, and the highest SEER revenue forecast at $1,236,584,779. On average, 2 Wall Street analysts forecast SEER's revenue for 2025 to be $1,904,461,038, with the lowest SEER revenue forecast at $1,893,320,051, and the highest SEER revenue forecast at $1,915,602,025.
In 2026, SEER is forecast to generate $2,963,308,212 in revenue, with the lowest revenue forecast at $2,800,727,530 and the highest revenue forecast at $3,125,953,667.